Diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid Side Effects
Applies to diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid: intramuscular suspension.
Warning
Your child should not receive a booster vaccine if he or she had a life threatening allergic reaction after the first shot.
Get emergency medical help if your child has signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Your child should not receive a booster vaccine if he or she had a life threatening allergic reaction after the first shot. Keep track of all side effects your child has. If the child receives a booster dose, tell the vaccination provider if the previous shot caused any side effects.
Call your doctor at once if your child has:
-
breathing that stops during sleep;
-
unusual pain or discomfort;
-
weakness; or
-
problems with vision, hearing, or muscle movement.
Becoming infected with diphtheria, haemophilus B, hepatitis B, pertussis, polio, or tetanus is much more dangerous to your child's health than receiving this vaccine. However, like any medicine, this vaccine can cause side effects.
Common side effects may include:
-
fever of 100.4 degrees F or higher;
-
fussiness, crying more than usual;
-
vomiting, decreased hunger; or
-
drowsiness; or
-
pain, swelling, or redness where the shot was given.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to diphtheria toxoid/haemophilus b conjugate (prp-omp) vaccine/hepatitis b pediatric vaccine/pertussis, acellular/poliovirus vaccine, inactivated/tetanus toxoid: intramuscular suspension.
General
The most frequently reported adverse reactions were irritability, crying, somnolence, injection site reactions (pain, erythema, swelling), fever, decreased appetite, and vomiting.[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Pallor[Ref]
Dermatologic
Uncommon (0.1% to 1%): Rash, hyperhidrosis[Ref]
Gastrointestinal
Very common (10% or more): Vomiting (up to 13.1%)
Common (1% to 10%): Diarrhea
Uncommon (0.1% to 1%): Abdominal pain[Ref]
Hematologic
Uncommon (0.1% to 1%): Lymphadenopathy[Ref]
Hypersensitivity
Postmarketing reports: Hypersensitivity (includes rash, urticaria, dyspnea, erythema multiforme), anaphylactic reaction (includes urticaria, angioedema, edema, face edema, and shock)[Ref]
Local
Very common (10% or more): Injection site pain (up to 53.3%), injection site erythema (up to 31.8%), injection site swelling (up to 23.4%)
Common (1% to 10%): Injection site bruising, injection site induration, injection site nodule
Uncommon (0.1% to 1%): Injection site rash, injection site warmth, tenderness
Postmarketing reports: Extensive swelling of injected limb (includes adjacent joints)[Ref]
Metabolic
Very common (10% or more): Decreased appetite (up to 28.9%)
Uncommon (0.1% to 1%): Increased appetite[Ref]
Nervous system
Very common (10% or more): Somnolence (up to 56.3%)
Uncommon (0.1% to 1%): Hypotonia
Postmarketing reports: Seizure, febrile seizure, hypotonic-hyporesponsive episode (HHE), convulsions with or without fever[Ref]
Other
Very common (10% or more): Crying (up to 52%), fever (38C or higher) (up to 29.3%)
Uncommon (0.1% to 1%): Death, fatigue[Ref]
In 2 US studies, death was reported in 6 participants (0.2%). None were assessed as vaccine related. Causes of death included asphyxia, hydrocephalus, unknown cause, sepsis, and 2 cases of sudden infant death syndrome occurring 1, 2, 10, 42, 44, and 49 days post-vaccination, respectively.[Ref]
Psychiatric
Very common (10% or more): Irritability (up to 61.8%)
Uncommon (0.1% to 1%): Sleep disorders (includes insomnia, restlessness)[Ref]
Respiratory
Uncommon (0.1% to 1%): Rhinitis, cough
Frequency not reported: Apnea[Ref]
More about diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: vaccine combinations
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. Product Information. Vaxelis (diphtheria/haemophilus conjugate (PRP-OMP)/hepatitis B/pertussis,acellular/poliovirus/tetanus). Maxx Pharma Pty Ltd. 2023.
2. Product Information. Vaxelis (diphtheria/haem/hepB/pert,acel/polio/tetan). Merck & Co., Inc. 2022.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.